Related Experiment Video
Updated: Jul 10, 2026

04:17
DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning
Published on: May 10, 2024
Rapid detection of important human pathogenic Phleboviruses
Manfred Weidmann1, M Paz Sanchez-Seco, Amadou A Sall
1Institute of Virology, University of Göttingen, Kreuzbergring 57, 37075 Göttingen, Germany. mweidma@gwdg.de
Summary
New RT-PCR assays were developed for diagnosing Sandfly Fever Sicilian virus (SFSV), Sandfly Fever Naples virus (SFNV), Toscana virus (TOSV), and Rift Valley Fever virus (RVFV), improving phlebovirus surveillance.
Area of Science:
- Virology
- Molecular Biology
- Public Health
Background:
- Phleboviruses are significant human pathogens within the Bunyaviridae family.
- Current diagnostic tools for many phleboviruses are limited, hindering effective surveillance and control.
- Rapid and accurate detection methods are crucial for managing outbreaks caused by these viruses.
Purpose of the Study:
- To develop and evaluate novel reverse transcription-polymerase chain reaction (RT-PCR) assays.
- The assays target four key human pathogenic phleboviruses: Sandfly Fever Sicilian virus (SFSV), Sandfly Fever Naples virus (SFNV), Toscana virus (TOSV), and Rift Valley Fever virus (RVFV).
Main Methods:
- Generation of specific RNA standards for assay calibration and validation.
- Performance testing of the developed RT-PCR assays using these RNA standards.
- Evaluation of assay sensitivity and detection limits.
Main Results:
- RT-PCR assays demonstrated high sensitivity, with detection limits of 10-100 RNA molecules for SFSV, TOSV, and RVFV.
- The TOSV assay successfully identified recent viral isolates from Spain.
- The RVFV assay detected recent isolates originating from Africa.
Conclusions:
- The developed RT-PCR assays provide sensitive and specific tools for phlebovirus detection.
- These assays are expected to significantly enhance the surveillance of pathogenic phleboviruses.
- Improved diagnostics will aid in the timely identification and management of phlebovirus infections.

